DMII (Drugs Made In America Acquisition II) Accounts Payable & Accrued Expense: $0.20 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DMII Drugs Made In America Acquisition II Corp DMII
14 GF Score
Price $10.17
! 2 Warning Signs
View Full Analysis

What is Drugs Made In America Acquisition II Accounts Payable & Accrued Expense?

Drugs Made In America Acquisition II DMII 14 Accounts Payable & Accrued Expense is $0.20 Mil as of Jun. 2026. GuruFocus rates DMII with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Drugs Made In America Acquisition II's quarterly accounts payable & accrued expense declined from Dec. 2025 ($0.30 Mil) to Mar. 2026 ($0.22 Mil) and declined from Mar. 2026 ($0.22 Mil) to Jun. 2026 ($0.20 Mil).

Drugs Made In America Acquisition II's annual accounts payable & accrued expense increased from . 20 ($0.00 Mil) to Dec. 2024 ($0.01 Mil) and increased from Dec. 2024 ($0.01 Mil) to Dec. 2025 ($0.30 Mil).

Drugs Made In America Acquisition II Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition II's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II Accounts Payable & Accrued Expense Chart

Drugs Made In America Acquisition II Annual Data
Trend Dec24 Dec25
Accounts Payable & Accrued Expense
0.01 0.30

Drugs Made In America Acquisition II Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial 0.03 0.12 0.30 0.22 0.20
DMII
14GF Score
Drugs Made In America Acquisition II Corp DMII
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of $0.20 Mil mean?
Drugs Made In America Acquisition II (DMII) has a Accounts Payable & Accrued Expense of $0.20 Mil as of Jun. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Drugs Made In America Acquisition II and its competitors.
Is Drugs Made In America Acquisition II's Accounts Payable & Accrued Expense too high?
Drugs Made In America Acquisition II's current Accounts Payable & Accrued Expense is $0.20 Mil. Overall, Drugs Made In America Acquisition II has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's Accounts Payable & Accrued Expense compare to EVAC and CXII?
Drugs Made In America Acquisition II's Accounts Payable & Accrued Expense of $0.20 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Diversified Financial Services company?
A good Accounts Payable & Accrued Expense depends on the Diversified Financial Services industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current Accounts Payable & Accrued Expense is $0.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current Accounts Payable & Accrued Expense of $0.20 Mil. The current Accounts Payable & Accrued Expense is $0.20 Mil. Drugs Made In America Acquisition II's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current Accounts Payable & Accrued Expense is $0.20 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
14GF Score

Get the complete analysis for DMII

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.17
Price